Literature DB >> 26592460

SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.

Emil Carlsson1, Jeak Ling Ding2, Bernadette Byrne3.   

Abstract

Toll-like receptors (TLRs) recognise invading pathogens and initiate an innate immune response by recruiting intracellular adaptor proteins via heterotypic Toll/interleukin-1 receptor (TIR) domain interactions. Of the five TIR domain-containing adaptor proteins identified, Sterile α- and armadillo-motif-containing protein (SARM) is functionally unique; suppressing immune signalling instead of promoting it. Here we demonstrate that the recombinantly expressed and purified SARM TIR domain interacts with both the major human TLR adaptors, MyD88 and TRIF. A single glycine residue located in the BB-loop of the SARM TIR domain, G601, was identified as essential for interaction. A short peptide derived from this motif was also found to interact with MyD88 in vitro. SARM expression in HEK293 cells was found to significantly suppress lipopolysaccharide (LPS)-mediated upregulation of inflammatory cytokines, IL-8 and TNF-α, an effect lost in the G601A mutant. The same result was observed with cytokine activation initiated by MyD88 expression and stimulation of TLR2 with lipoteichoic acid (LTA), suggesting that SARM is capable of suppressing both TRIF- and MyD88- dependent TLR signalling. Our findings indicate that SARM acts on a broader set of target proteins than previously thought, and that the BB-loop motif is functionally important, giving further insight into the endogenous mechanisms used to suppress inflammation in immune cells.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunomodulation; Innate immunity; Sterile α­ and armadillo­motif­containing protein (SARM); TIR domain; TLR signalling

Mesh:

Substances:

Year:  2015        PMID: 26592460     DOI: 10.1016/j.bbamcr.2015.11.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

Review 1.  Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.

Authors:  Heather S Loring; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2019-11-21       Impact factor: 8.116

Review 2.  The Toll Pathway in the Central Nervous System of Flies and Mammals.

Authors:  Anat Shmueli; Tali Shalit; Eitan Okun; Galit Shohat-Ophir
Journal:  Neuromolecular Med       Date:  2018-10-01       Impact factor: 3.843

Review 3.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

4.  Sexually dimorphic effects of SARM1 deletion on cardiac NAD+ metabolism and function.

Authors:  Hina Lateef Nizami; Keaton E Minor; Ying Ann Chiao; Christine M Light; Chi Fung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-09-02       Impact factor: 5.125

Review 5.  Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Authors:  Caroline Fernandes-Santos; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 6.  Molecular mechanisms of regulation of Toll-like receptor signaling.

Authors:  Cynthia A Leifer; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2016-06-24       Impact factor: 4.962

7.  SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.

Authors:  Daniel W Summers; Daniel A Gibson; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

Review 8.  A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity.

Authors:  Eleanor L Hopkins; Weixi Gu; Bostjan Kobe; Michael P Coleman
Journal:  Front Mol Biosci       Date:  2021-07-08

9.  Pre- and post-conditioning with poly I:C exerts neuroprotective effect against cerebral ischemia injury in animal models: A systematic review and meta-analysis.

Authors:  Zeeshan Ahmad Khan; Dewan Md Sumsuzzman; Jeonghyun Choi; George Kamenos; Yonggeun Hong
Journal:  CNS Neurosci Ther       Date:  2022-05-05       Impact factor: 7.035

10.  A phase transition enhances the catalytic activity of SARM1, an NAD+ glycohydrolase involved in neurodegeneration.

Authors:  Heather S Loring; Victoria L Czech; Janneke D Icso; Lauren O'Connor; Sangram S Parelkar; Alexandra B Byrne; Paul R Thompson
Journal:  Elife       Date:  2021-06-29       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.